Andere Sprachen Invion Limited

Aktien

A1J3RR

AU000000IVX4

IVX

Markt geschlossen - Australian S.E. Andere Börsenplätze 08:10:12 03.05.2024			% 5 Tage	% 1. Jan.
0,005 ^AUD	-16,67 %		-16,67 %	0,00 %

05.03.	Invion's Anti-Krebs-Medikament meldet postive präklinische Studienergebnisse	MT
27.02.	Invion Limited meldet Ergebnis für das Halbjahr bis zum 31. Dezember 2023	CI

Andere Sprachen

Erhalten Sie Zugang zu allen Nachrichten über alle Unternehmen: Verpassen Sie keine profitable Anlagechance mehr!

100% kostenlose Registrierung

Invion's Anti-Cancer Drug Logs Postive Preclinical Trial Results	05.03.
Invion Limited Reports Earnings Results for the Half Year Ended December 31, 2023	27.02.
Invion Signs Collaboration Agreement with Dr. I&B Co for HPV Treatment; Shares Up 25%	23.02.
Invion Nears Clinical Trial of Cancer Photodynamic Therapy with Drug Substance Production	21.11.
Invion Grants RMW Cho Group Right to Distribute Cancer Treatment Products in South Korea	26.09.23
Invion Limited Reports Earnings Results for the Full Year Ended June 30, 2023	31.08.23
Invion Launches New Interactive Investor Hub	11.04.23
Invion Limited agreed to acquire Next Generation Photodynamic Therapy of RMW Cho Group Limited.	06.04.23
Invion Limited Reports Earnings Results for the Half Year Ended December 31, 2022	22.02.23
Invion Expanding Photosoft Technology Rights to US, Canada, Hong Kong	08.02.23
Invion Limited Announces Vitro Test Results on Photosoft	26.10.22
Invion Limited Announces the Positive Screening Results from in Vitro Studies of PhotosoftTM on the Inhibition of the Dengue Virus	24.10.22
Invion Validates Efficacy of Photodynamic Drug Against Anal Cancer	15.09.22
Invion Limited Announces INV043 Effective Against Anal Cancer Squamous Cell Carcinomas in Vitro	15.09.22
Invion Limited Announces PhotosoftTM Shows Activity Against Zika Virus in Preliminary Assays	08.09.22
Invion Limited Reports Earnings Results for the Full Year Ended June 30, 2022	18.08.22
Invion : Activities Report and Appendix 4C	21.07.22
Invion : Notification regarding unquoted securities - IVX	20.06.22
Invion's Cancer Treatment Patent Application Published	09.06.22
Invion Limited Announces International Patent to Extend IP Protection for Photosoft	08.06.22

Keine Ergebnisse zu dieser Suche

Alle Nachrichten Analystenempfehlungen Wichtige Fakten Insiders Transkripte Pressemitteilungen Offizielle Publikationen Andere Sprachen Trading-Ideen MarketScreener Artikel MarketScreener Analysen

Andere Sprachen Invion Limited

Aktien

A1J3RR

AU000000IVX4

IVX

Andere Sprachen

Filter